Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Melincoff Gwen A Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Melincoff Gwen A (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.
Txns: Granted 61,676 options to buy @ $1.66, valued at $102.4k
05/26/2023 4 Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Granted 2,666 options to buy @ $5.03, valued at $13.4k
Granted 10,000 options to buy @ $5.25, valued at $52.5k
05/19/2023 4 Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
10/14/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC
10/14/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Granted 2,666 options to buy @ $0
09/22/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns: Granted 10,500 options to buy @ $3.5, valued at $36.8k
09/09/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.
Txns: Granted 50,000 options to buy @ $1.03, valued at $51.5k
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/22/2020 4 Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 4,047 shares @ $0
Granted 8,095 options to buy @ $22.05, valued at $178.5k
05/20/2020 4 Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Granted 9,530 options to buy @ $3.41, valued at $32.5k
01/22/2020 4 Melincoff Gwen A (Director) has filed a Form 4 on Protalix BioTherapeutics, Inc.
Txns: Granted 40,000 options to buy @ $3.55, valued at $142k
11/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2019 4 Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Granted 13,000 options to buy @ $2.5, valued at $32.5k
04/29/2019 4 Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 4,707 shares @ $0
Granted 9,414 options to buy @ $14.57, valued at $137.2k
04/29/2019 4 Melincoff Gwen A (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Granted 20,000 options to buy @ $1.98, valued at $39.6k
05/29/2018 4 Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 2,253 shares @ $0
Granted 4,506 options to buy @ $24.95, valued at $112.4k
08/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2016 4 Melincoff Gwen A (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns: Disposed/sold 13,539 options to buy @ $8.13, valued at $110.1k
Disposed/sold 15,500 options to buy @ $16.52, valued at $256.1k
Disposed/sold 17,778 options to buy @ $7.91, valued at $140.6k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy